But it’s not CEO Mark Freeman’s only worry. Australian Foundation Investment Company boss Mark Freeman says buying CSL and Resmed amid last year’s Ozempic rout was part of a tried-and-true ...
Trump Asserts a Muscular Vision of Presidential Power as He Takes Over In a flurry of executive actions, President Trump revived disputed claims of broad presidential authority from his first term ...
There are seven women who remain on the list of 33 hostages expected to be released from Hamas captivity in the first phase of the hostage deal. Information ...
A man looks at an electronic board displaying the Nikkei stock average outside a brokerage in Tokyo, Japan, August 6, 2024. REUTERS/Willy Kurniawan/File Photo A look at the day ahead in Asian markets.